Eco Animal Health revenues offset by rising costs
Eco Animal Health, which specialises in the development and marketing of medicines for the control of disease in livestock, saw its pre-tax profit for the year creep higher after revenue gains were slightly offset by rising sales costs.
Eco Animal Health, which specialises in the development and marketing of medicines for the control of disease in livestock, saw its pre-tax profit for the year creep higher after revenue gains were slightly offset by rising sales costs.
Pre-tax profit was £2.32m (2011: £2.29m) on revenues of £28.3m (2011: £27.1m), while the cost of sales increased from £16.4m to £17.5m year-on-year.
A small amount of additional income (£0.76m compared to £0.18m the previous year) helped to boost profits higher.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Diluted earnings per share were 4.19p against 2.96p the previous year, with income pushed higher by the continued growth of the consumption of meat protein and the animal industry.
UK sales grew more than 30% during the year, reflecting the continued success of its direct-to-market strategy with its Aivlosin product.
Peter Lawrence, Executive Chairman of ECO Animal Health Group, said: "ECO has delivered another strong set of results for the year ended March 31st and the current year has started well.
"We are confident that the long awaited marketing authorisations in the US and Canada will have a major positive effect on the development of ECO, although it will be some months before the product launches gain momentum. We do not expect a noticeable impact on our financial performance until next year.
"ECO is very well placed to further broaden its product ranges and its global reach will ensure that it capitalises on opportunities as they arise in all the Company's major markets."
The share price fell 0.39% o 256.50p by 12:10.
NR
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Review: Eden Roc Cap Cana – fun, sun and golf in the Caribbean
Travel Eden Roc Cap Cana in the Dominican Republic offers everything from relaxing by the pool to a world-class golf course
-
Reeves delays cash ISA reform, but savers are not out of the woods yet
The chancellor has reportedly delayed plans to cut the cash ISA limit, which were set to be announced at Mansion House on 15 July, and will take more time to consult with the industry